Welcome to our dedicated page for GBT Technologies SEC filings (Ticker: GTCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GBT Technologies Inc. filings document material events, governance changes and reporting obligations for a Nevada public company quoted on the OTC Pink market. The company’s Form 8-K reports cover executive appointments, board changes, employment agreements, auditor matters and the formation of wholly owned subsidiaries tied to smart wellness machines and digital media distribution.
Regulatory disclosures also describe capital-structure and compensation terms involving common stock, securities not registered on a national exchange, annual-report timing through Form 12b-25 notices, and exhibits such as press releases and employment agreements. The filing record frames GBT’s AI, IoT and interactive-machine initiatives alongside public-company governance and financial-reporting requirements.
GBT Technologies Inc. (GTCH) reports third-quarter 2025 results showing continued losses and a highly leveraged balance sheet. For the three months ended September 30, 2025, the company recorded a net loss of $180,640, compared with net income of $6,276,094 in the prior-year quarter that had been boosted by large non-cash gains from derivative revaluations and debt settlements. For the nine months of 2025, GBT posted a net loss of $498,594, versus net income of $14,501,569 a year earlier.
The balance sheet remains weak, with cash of $813, total assets of $7,090 and total liabilities of $10,673,007, resulting in a stockholders’ deficit of $10,665,917 as of September 30, 2025. Management discloses an accumulated deficit of $295,774,377 and a working capital deficit of $10,422,177, and states that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
GBT has significant convertible debt, including notes to Igor 1 Corp., Glen Eagle and related party Stanley Hills, plus an SBA loan, all of which may be settled in stock at low fixed prices. Potentially dilutive instruments total 637,498,005,791 shares compared with 18,492,870,775 common shares outstanding as of November 14, 2025. The company also holds stakes in VisionWave Holdings, Inc. (VWAV) and Avant Technologies, Inc. (AVAI), and after the balance-sheet date granted Boca Jom LLC an exclusive patent license in exchange for a 5% running royalty on patent-derived revenue.